New “black box” warning on controversial antibiotic

Categories: Prescription Drugs

The FDA announced that the antibiotic Ketek, used to treat pneumonia, must come with a new “black box label” — the strongest warning the agency can impose on a drug. Additionally, Ketek can no longer be recommended for treating milder conditions such as sinusitis and bronchitis. The changes come after the medication was found to cause serious liver damage in studies.

Forbes.com states:

The drug and the related approval process have been dogged by criticism … Last June, Sanofi-Aventis agreed to update Ketek’s labeling to reflect the possibility of severe liver damage. And last month, a European Medicines Agency panel recommended that Ketek not be given to patients with a history of such liver conditions as hepatitis or jaundice.

Sanofi-Aventis is currently under investigation by both the U.S. House and Senate for irregularities during the approval process.

About Cary Byrd

eDrugSearch founder, Cary Byrd, has been called an “e-health innovator” by MarketIntellNow, interviewed by top pharmaceutical industry journalists, invited to Matthew Holt’s Health 2.0 Conference and a Consumer Report's health summit, and highlighted on numerous health blogs.

eDrugSearch.com - Search. Compare. Save.

Leave a Reply

Join Our Free Newsletter

Please enter email id

Get a weekly dose of money-saving tips on your medications, drug side effects alerts, drug interaction warnings, free prescription coupons, late-breaking safety information and much, much more!

Share via
Copy link